Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: Economic analysis of CALGB/SWOG 80405.
- Citation:
- J Clin Oncol vol 33 (suppl) abstr 6504
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Health Outcomes
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA037447
- Corr. Author:
- Authors:
- Deborah Schrag Amylou C. Dueck Michelle Joy Naughton Donna Niedzwiecki Craig Earle James Edward Shaw Axel Grothey Howard S. Hochster Charles David Blanke Alan P. Venook
- Networks:
- CA824, CAPITAL, LAPS-MN026, LAPS-NY016, LAPS-OH007, OR013
- Study
- CALGB-70502
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80405
- Phases:
- N/A, 3
- Keywords: